Nephro Care India Limited (NSE:NEPHROCARE)

Nephro Care India Statistics

Total Valuation

NSE:NEPHROCARE has a market cap or net worth of INR 1.65 billion. The enterprise value is 1.51 billion.

Market Cap	1.65B
Enterprise Value	1.51B

Important Dates

The next estimated earnings date is Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:NEPHROCARE has 16.49 million shares outstanding. The number of shares has increased by 39.12% in one year.

Current Share Class	16.49M
Shares Outstanding	16.49M
Shares Change (YoY)	+39.12%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	65.71%
Owned by Institutions (%)	5.95%
Float	5.65M

Valuation Ratios

The trailing PE ratio is 48.45.

PE Ratio	48.45
Forward PE	n/a
PS Ratio	2.43
PB Ratio	2.97
P/TBV Ratio	2.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.39, with an EV/FCF ratio of -20.51.

EV / Earnings	44.34
EV / Sales	2.23
EV / EBITDA	27.39
EV / EBIT	44.45
EV / FCF	-20.51

Financial Position

The company has a current ratio of 2.45

Current Ratio	2.45
Quick Ratio	1.76
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	40.74

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.05%
Return on Capital Employed (ROCE)	6.02%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.03M
Profits Per Employee	101,716
Employee Count	334
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:NEPHROCARE has paid 12.07 million in taxes.

Income Tax	12.07M
Effective Tax Rate	26.21%

Stock Price Statistics

The stock price has decreased by -44.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-44.15%
50-Day Moving Average	123.31
200-Day Moving Average	135.97
Relative Strength Index (RSI)	30.87
Average Volume (20 Days)	10,580

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:NEPHROCARE had revenue of INR 676.68 million and earned 33.97 million in profits. Earnings per share was 2.06.

Revenue	676.68M
Gross Profit	368.46M
Operating Income	33.89M
Pretax Income	46.04M
Net Income	33.97M
EBITDA	55.00M
EBIT	33.89M
Earnings Per Share (EPS)	2.06

Balance Sheet

The company has 140.51 million in cash and n/a in debt, with a net cash position of 140.51 million or 8.52 per share.

Cash & Cash Equivalents	140.51M
Total Debt	n/a
Net Cash	140.51M
Net Cash Per Share	8.52
Equity (Book Value)	554.28M
Book Value Per Share	33.65
Working Capital	153.32M

Cash Flow

In the last 12 months, operating cash flow was -25.47 million and capital expenditures -47.98 million, giving a free cash flow of -73.45 million.

Operating Cash Flow	-25.47M
Capital Expenditures	-47.98M
Free Cash Flow	-73.45M
FCF Per Share	-4.46

Margins

Gross margin is 54.45%, with operating and profit margins of 5.01% and 5.02%.

Gross Margin	54.45%
Operating Margin	5.01%
Pretax Margin	6.80%
Profit Margin	5.02%
EBITDA Margin	8.13%
EBIT Margin	5.01%
FCF Margin	n/a

Dividends & Yields

NSE:NEPHROCARE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.12%
Shareholder Yield	-39.12%
Earnings Yield	2.06%
FCF Yield	-4.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NSE:NEPHROCARE has an Altman Z-Score of 16.66 and a Piotroski F-Score of 2.

Altman Z-Score	16.66
Piotroski F-Score	2